Back

Deciphering the mechanism of transthyretin-induced cardiotoxicity in vitro

19 April 2026 (10:05 - 10:55)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies and valvular heart disease Cardiomyopathies Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Miss Angeliki Choustoulaki

National & Kapodistrian University of Athens, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
DSP-AS1 lncRNA as a promising target for treating desmoplakin cardiomyopathy
Doctor M. De Bortoli (Bozen, IT)
Abstract
Presentation thumbnail
Modeling restrictive cardiomyopathy caused by tnni3 mutations using patient-derived ipsc-cardiomyocytes, cardiac spheroids, and engineered heart tissues
Assistant Professor F. Stillitano (Utrecht, NL)
Abstract
Presentation thumbnail
Longitudinal proteomics resolves spatio-temporal cardiac remodeling consequent to cardiomyocyte-specific knockdown of Pkp2
Doctor J. Achter (Copenhagen, DK)
Abstract
Presentation thumbnail
Integrative omics to reveal endothelial mesenchymal transition as critical biological function associated with poor reverse cardiac remodelling in aortic stenosis patients
Doctor R. Garcia (Santander, ES)
Abstract

Access the full session

Session thumbnail
Cardiomyopathies and valvular heart disease

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

19 April 2026 10:05 CET
You may be interested in
thumbnail
Congress Session
When time is the issue
thumbnail
Congress Session
Genetics in heart failure
thumbnail
Congress Session
When external causes are the villain?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources